We are a Chilean biotech company that enables the availability of products and services that improve the quality of life for humans and animals worldwide. We have a team of professionals with over 14 years experience in development of applied science and patents to contribute to a more good. Bioingentech mission is to provide new tools of high-quality to the communities and better services for all contributing to the Global Public Good.
More information on Bioingentech, could you send us an email to [email protected]
Company Timeline
October , 2006
Company creation
Bioingentech is founded in October of year 2006 in Concepción Chile.
2006
Bird Sexing Service
We started with genetics bird sexing in Santiago. Then we moved to Concepción and we get a Innovabiobio (CORFO) support as seed capital. We obtained U$50.000 and we contribute with U$50.000. We finished the methodological develop for genetics detection of specific genes that is known affect bird, dog and cat health.
2008
Genetic Test in Human
We complete the methodologies develop implementation for genetics detection of specific genes that is known affect Human health.
2008
Proyect INNOVA BIO-BIO
Papilloma virus Multiplex PCR for cancer high risk strains
Sponsored: UDEC – IDEA INCUBA.
Project Code: 443
INNOVABIOBIO contribution: U$ 7.900
Bioingentech contribution: U$ 16.100
2009
Validation for diagnostic human
We develop a Clinic trials for methodology validation along with the “Hospital Guillermo Grantt Benanvente – Concepción” and the support of Dra. Nancy Henríquez Microbiology Laboratory chief. We achieve a primary validation for diagnostic methodologies for genetics detection of specific genes that is known affect Human health like Hanta Virus, CMV, HSV1, Mycoplasma and Mycobacterium Tuberculosis.
2010
Proyect Incuba UDEC
We obtained Innovabiobio support in its 6° contest for the implementation a diagnostic methodology for Human Papilloma virus detection (6, 11, 16, 18, 31, 33, 45, 52 and 58 strains). This project was supported also by Incuba UDEC.
2011
Proyect INNOVA BIO-BIO
We obtained resources for the genomic services internalization into bird industry by CORFO contest.
Internalization of genomic services for Birds industry.
Project Code: 10-IE S5-809
INNOVAChile contribution: U$ 68.000
Bioingentech contribution: U$ 54.000
2012
Conventional PCR Veterinary
We obtained resources for develop genetic veterinary pathogen detection medical devices by Conventional PCR (end point technology). We accomplished more than 100 different pathogens medical devices.
2013
Services y product veterinary
We internalized the veterinary genomic services and the merchandising of the medical devices for Biomedicine and veterinary pathogen detection.
2014
Proyect CONICYT
Development of exotic animal pathogen diagnostic devices.
Project Code: 781303021
CONICYT Contribution: U$ 62.000
2015
PCR Real-Time
We obtained resources for develop Biomedical and Veterinary medical devices with the Real Time technology (5′ Nucleases technology).
2015
Proyect CORFO
Development of important Biomedicine ITS pathogen medical devices by Multiple PCR detection.
Project Code: 15CH-46465
INNOVACHILE Contribution: U$ 57.500
Bioingentech contribution: U$ 45.000
2016
Conference
We were chosen for participate in the world Biotechnology Conference made in San Francisco, California, USA. Also we started the Recombinant enzymes production for the Agropecuary, energetic, food and petrochemical Industry.
2016
Proyect CORFO
Development a procedure for industrial Enzymes production.
Project Code: 15CH-46465
CORFO Contribution: U$ 48.000
Bioingentech contribution: U$ 36.500
2017
CORFO
We obtained “Best Chilean Biomedicine Company Award” by CORFO during a recognition and results presentation ceremony for the project of “Programa Capital Humano Avanzado 2016, CORFO” done in November 24, 2017.
2018
Biotherapeutics
We obtained a feasibility report in clinical trials made on Camels from UEA for our first Camelpox Biotherapeutics.
We are making economic and scientific research in Immunotherapy and Biopharmacs.
2019
Agreement with Labvima SH laboratory
Agreement with the Labvima SH laboratory, for the development of PCR Multiplex Mastitis and other pathogens that affect the livestock and dairy industry.